Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo
about
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expressionCHD1 and CHD2 are positive regulators of HIV-1 gene expressionHow to Define the Latent Reservoir: Tools of the TradeHIV restriction in quiescent CD4⁺ T cellsRecent developments in human immunodeficiency virus-1 latency researchAn HIV feedback resistor: auto-regulatory circuit deactivator and noise bufferViral and latent reservoir persistence in HIV-1-infected patients on therapyTherapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTActivation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapyDirectly infected resting CD4+T cells can produce HIV Gag without spreading infection in a model of HIV latencyProfound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infectionA Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes.Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTRLimits on replenishment of the resting CD4+ T cell reservoir for HIV in patients on HAARTLow-level HIV-1 replication and the dynamics of the resting CD4+ T cell reservoir for HIV-1 in the setting of HAART.CpG methylation controls reactivation of HIV from latency.Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activationExpression of Herpes Simplex Virus Thymidine Kinase/Ganciclovir by RNA Trans-Splicing Induces Selective Killing of HIV-Producing Cells.A novel assay allows genotyping of the latent reservoir for human immunodeficiency virus type 1 in the resting CD4+ T cells of viremic patients.Human immunodeficiency virus Tat associates with a specific set of cellular RNAsHuman immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli.Hexamethylbisacetamide remodels the human immunodeficiency virus type 1 (HIV-1) promoter and induces Tat-independent HIV-1 expression but blunts cell activationGag-positive reservoir cells are susceptible to HIV-specific cytotoxic T lymphocyte mediated clearance in vitro and can be detected in vivo [corrected]Mini ways to stop a virus: microRNAs and HIV-1 replicationAnalysis of multiply spliced transcripts in lymphoid tissue reservoirs of rhesus macaques infected with RT-SHIV during HAARTSulfonation pathway inhibitors block reactivation of latent HIV-1.Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activityA Novel Assay to Measure the Magnitude of the Inducible Viral Reservoir in HIV-infected IndividualsProductive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.Transcriptomic Analysis Implicates the p53 Signaling Pathway in the Establishment of HIV-1 Latency in Central Memory CD4 T Cells in an In Vitro Model.Molecular mechanisms of HIV latency.HIV-specific CD8⁺ T cells and HIV eradicationExperimental approaches to the study of HIV-1 latency.A Minor Subset of Super Elongation Complexes Plays a Predominant Role in Reversing HIV-1 Latency.A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral Therapy.HIV reservoirs and latency models.Cell-associated HIV RNA: a dynamic biomarker of viral persistence.Regulation of HIV-1 latency by T-cell activation.
P2860
Q21245193-4770A95F-C6E7-47BD-BE4A-35384EF920C9Q24305354-A9C1624A-1C1B-41E0-B85D-E5E5544AEECEQ26766705-B6D43482-D500-49E5-AB80-96ADA406B063Q26995784-513981A6-09A9-454D-A641-8F8DCE4D7B43Q27013114-A30E19FB-1CD5-47E6-A8E9-E5B34FB6218FQ27334904-3B781A6B-5AA8-45D2-9EDF-49C5BC888ECBQ28469057-93228867-3B37-497E-8388-2601F1F1A97CQ28476094-2E56FAE4-C28E-4019-8A04-CA420EC27DC5Q28544949-160A7844-6FD8-4442-BB0F-6B96B0B4D054Q28728736-0842C980-4E95-45EE-86CB-3BA705AF9F9CQ28748901-29E7BADD-E2B7-423E-AEB3-FB87D5DCE1C9Q30385378-C435DA8A-C203-415D-9BB2-1FC85733E6FFQ30480091-B03BC284-7D5B-4959-9B95-4EA7F40BCE1BQ33250088-9359762B-4134-406C-971D-5CE8B0297A2DQ33292464-79CDD8D0-114E-40E8-B66A-29429C97C024Q33296883-3418C6A3-DB29-4200-87B0-7646D66626EAQ33313038-80272301-4855-4417-ACE2-828EC0B95FF6Q33495565-5EE8575C-A1E0-4C62-A72C-F1395FB30386Q33508788-1F7A8DA8-889C-4A1B-B0EF-168168C0A1C0Q33635315-C1631046-59B6-461A-9F8E-DC39AFB1250DQ33724247-F87E0FF2-853A-4FC8-98E6-A2527A31989FQ33863026-755414AE-E649-4621-BC9F-1221AAAEB102Q34124009-550117C0-E135-4DFB-BB91-D22B9A1B9EBCQ34647406-8069E5B1-7177-4ECB-A959-E3E334C3F882Q34950830-99B98F07-DD6B-489F-8AE2-59CB31D2431AQ35055688-44E3D528-AE7E-490D-A926-66A38445FFD3Q35088292-B4EC4FC5-351E-42E0-8CEA-19DA10D4750BQ35358497-E48C78A9-87AD-45EA-B402-A711251217E8Q35761152-83622439-C2DE-4C76-AE74-10E0D15A0098Q36038655-B49330D6-0F59-419D-BAA0-A36164DB7379Q36098975-5A4ADD99-0334-4C43-AF51-207B55B3F875Q36206925-1087D145-57D3-4D1D-964E-16E4737B4E78Q36515063-A7488F98-904A-461F-98EA-2353C2766F4EQ36515071-C9672B9D-5B1C-4188-A6DF-EFFF25C586D4Q36708954-A184619B-A85E-4B93-B7DB-F9405A0B324CQ36709227-D575DC5A-4CE1-4BEE-BFB3-3BCDBEB38D23Q36736780-2A966E4C-8011-4D95-B11C-B587EC0C7CB6Q36746403-DA218F68-6FEF-4112-80B2-FCA45BB0CCB6Q36798408-8B928FAF-CA61-4FE9-8957-44588AAFE573Q36887625-9E9DB822-9BAF-4077-AF31-3E02F6CBB28F
P2860
Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Analysis of human immunodefici ...... n resting CD4+ T cells in vivo
@en
Analysis of human immunodefici ...... resting CD4+ T cells in vivo.
@nl
type
label
Analysis of human immunodefici ...... n resting CD4+ T cells in vivo
@en
Analysis of human immunodefici ...... resting CD4+ T cells in vivo.
@nl
prefLabel
Analysis of human immunodefici ...... n resting CD4+ T cells in vivo
@en
Analysis of human immunodefici ...... resting CD4+ T cells in vivo.
@nl
P2860
P1433
P1476
Analysis of human immunodefici ...... n resting CD4+ T cells in vivo
@en
P2093
Justin R Bailey
Kara G Lassen
P2860
P304
P356
10.1128/JVI.78.17.9105-9114.2004
P407
P577
2004-09-01T00:00:00Z